Results 171 to 180 of about 984,321 (234)

Deubiquitinating enzymes in kidney diseases: Molecular mechanisms, pathological roles and therapeutic opportunities (Review). [PDF]

Mol Med Rep
Li Q, Ni Y, Li Z, Li J, Wang L.
europepmc   +1 more source

Walking Together: A Cross‐Cultural Study of the Relationship Between Religiosity and Substance Use Disorder

Nursing &Health Sciences, Volume 28, Issue 3, September 2026.
ABSTRACT The literature suggests that religiosity is a protective factor for substance use. However, individuals with substance use disorder (SUD) may actively cultivate their religiosity during substance use. This qualitative study analyzed the perceptions and meanings homeless people attribute to their substance use trajectories and religiosity, as ...
Camila Chagas, Leonardo Breno Martins, Tassiane Cristine Santos de Paula, Wellington Zangari, José Carlos Fernandes Galduróz   +4 more
wiley   +1 more source

Serotonin-Norepinephrine Reuptake Inhibitors in Fibromyalgia Management: An Integrative Literature Review of Clinical Evidence. [PDF]

Clin Pract
Lago IOD, Diniz BMM, Buchaim DV, Buchaim RL.   +3 more
europepmc   +1 more source

Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease

Veterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective Aqueous deficient dry eye disease (ADDE) results from a quantitative reduction in aqueous tears. We sought to determine the clinical effect of autologous mesenchymal stromal cell (MSC) injections into the region of the lacrimal gland and the gland of the third eyelid in immunomodulatory‐dependent ADDE‐affected dogs. Methods Dogs (n = 
Brian C. Leonard, Shin Ae Park, Sun Young Kim, Kei Hayashi, Sara M. Thomasy, Vanessa Rozo, Monica J. Motta, Dori L. Borjesson, Christopher J. Murphy, Kathryn L. Good   +9 more
wiley   +1 more source

USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). [PDF]

Int J Mol Med
Zhang L, Sun H, Wang Z, Wang Z, Mu Q, Liu Y.   +5 more
europepmc   +1 more source

Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) obtained by chemical synthesis as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Centro de Estudos Ameríndios da USP – CEstA

, 2011
CEstA, Centro de Estudos Ameríndios da USP
core   +1 more source

Correspondence to editorial on "RAB25/GCN1 signaling promotes endoplasmic reticulum stress to mediate alcohol-associated liver disease progression". [PDF]

Clin Mol Hepatol
Liu XW, Zhan ZB, Gong Y, Li ZH, Bai KH, Weng J.   +5 more
europepmc   +1 more source

Ubiquitin-specific protease 25: a new regulator for cardiovascular and cerebrovascular diseases. [PDF]

Front Cell Dev Biol
Shao Y, Jiang S, Zhai L, Sun F.
europepmc   +1 more source

USP10 regulates HIF2α stability by deubiquitinating HIF2α regardless of <i>VHL</i> status in kidney cancer. [PDF]

Transl Androl Urol
Xu S, Huang W, Ma B, Li X.
europepmc   +1 more source